HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer.
Boulbes DR, Arold ST, Chauhan GB, Blachno KV, Deng N, Chang WC, Jin Q, Huang TH, Hsu JM, Brady SW, Bartholomeusz C, Ladbury JE, Stone S, Yu D, Hung MC, Esteva FJ.
Boulbes DR, et al. Among authors: deng n.
Mol Oncol. 2015 Mar;9(3):586-600. doi: 10.1016/j.molonc.2014.10.011. Epub 2014 Nov 11.
Mol Oncol. 2015.
PMID: 25435280
Free PMC article.